Phosphoinositide 3-kinase signalling in the vascular system

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Research
• Cell Signaling

Background:

• Phosphoinositide 3-kinases (PI3Ks) are key enzymes activated by various membrane receptors.
• Distinct PI3K isoforms play critical roles in vascular physiology and pathology.
• PI3K-Akt signaling is implicated in vascular cells and atherosclerosis.

Purpose of the Study:

• To review recent advances in PI3K-Akt signaling within the vascular system.
• To discuss the role of PI3K isoforms in endothelial cells, vascular smooth muscle cells, platelets, and inflammatory cells.
• To explore the therapeutic potential of isoform-selective PI3K inhibitors for cardiovascular diseases.

Main Methods:

• Literature review of recent scientific publications.
• Synthesis of data on PI3K isoform functions in vascular cells.
• Analysis of the implications of PI3K signaling in atherosclerosis.
• Discussion of novel PI3K inhibitor drug development.

Main Results:

• PI3K isoforms have specific functions in vascular cells.
• PI3K-Akt pathway is involved in endothelial, smooth muscle, platelet, and inflammatory cell functions relevant to atherosclerosis.
• Isoform-selective PI3K inhibitors are emerging as promising therapeutic agents.

Conclusions:

• Targeting specific PI3K isoforms presents a novel approach for cardiovascular disease treatment.
• Understanding PI3K signaling in vascular cells is essential for developing effective therapies.
• Isoform-selective PI3K inhibitors offer potential for targeted treatment strategies in cardiovascular medicine.